Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Centessa Pharmaceuticals (CNTA) EPS (Basic) (2022 - 2025)

Historic EPS (Basic) for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to -$0.41.

  • Centessa Pharmaceuticals' EPS (Basic) fell 1081.08% to -$0.41 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of -$2.06 for FY2024, which is 3117.77% down from last year.
  • As of Q3 2025, Centessa Pharmaceuticals' EPS (Basic) stood at -$0.41, which was down 1081.08% from -$0.38 recorded in Q2 2025.
  • In the past 5 years, Centessa Pharmaceuticals' EPS (Basic) ranged from a high of -$0.2 in Q1 2025 and a low of -$0.97 during Q4 2024
  • Over the past 4 years, Centessa Pharmaceuticals' median EPS (Basic) value was -$0.4 (recorded in 2023), while the average stood at -$0.47.
  • In the last 5 years, Centessa Pharmaceuticals' EPS (Basic) soared by 6231.88% in 2023 and then tumbled by 16284.63% in 2024.
  • Over the past 4 years, Centessa Pharmaceuticals' EPS (Basic) (Quarter) stood at -$0.45 in 2022, then rose by 17.78% to -$0.37 in 2023, then crashed by 162.85% to -$0.97 in 2024, then skyrocketed by 57.84% to -$0.41 in 2025.
  • Its last three reported values are -$0.41 in Q3 2025, -$0.38 for Q2 2025, and -$0.2 during Q1 2025.